Vulvar cancer - Bergaoui, HAYFA;Dhekra, Toumi;Zouari, Ines
39,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Vulvar cancer is a rare condition, accounting for 4% of gynecological cancers and less than 1% of all female cancers.We conducted a retrospective descriptive study of 30 observations of vulvar cancer collected in the Obstetrics and Gynecology Department of Monastir over a period of 16 years. The objectives were to describe the epidemiologic-clinical profile and specify the therapeutic modalities of vulvar cancer.The average age of patients was 70 years. The average delay to consultation was 7 months. Clinical symptoms were dominated by pruritus and the perception of a vulvar tumour.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Vulvar cancer is a rare condition, accounting for 4% of gynecological cancers and less than 1% of all female cancers.We conducted a retrospective descriptive study of 30 observations of vulvar cancer collected in the Obstetrics and Gynecology Department of Monastir over a period of 16 years. The objectives were to describe the epidemiologic-clinical profile and specify the therapeutic modalities of vulvar cancer.The average age of patients was 70 years. The average delay to consultation was 7 months. Clinical symptoms were dominated by pruritus and the perception of a vulvar tumour. Ulcerative-bourgeous forms accounted for 50% of cases. Multifocal involvement was the most frequent, with a mean size of 4 cm.Overall survival at 5 years was 72.2%.Preventing vulvar cancer through early detection of at-risk groups and precancerous lesions remains the best way of combating this disease.
Autorenporträt
Außerordentliche Professorin für Gynäkologie und Geburtshilfe.Dozentin an der medizinischen Fakultät von Monastir und Sousse und der Schule für Gesundheit.